Open AccessPioglitazone Versus Glimepiride on Coronary Artery Calcium Progression in Patients With Type 2 Diabetes Mellitus
Author(s) -
Michael H. Davidson,
Craig A. Beam,
Steven M. Haffner,
Alfonso Pérez,
Ralph B. D’Agostino,
Theodore Mazzone
Publication year - 2010
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.110.207696
Subject(s) - pioglitazone , glimepiride , medicine , intima media thickness , type 2 diabetes mellitus , cardiology , diabetes mellitus , type 2 diabetes , endocrinology , carotid arteries
To compare coronary artery calcium (CAC) progression between 2 treatment groups, pioglitazone versus glimepiride.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom